Toews Corp Eli Lilly & CO Transaction History

Toews Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 03, 2021	SELL	$130.46 - $172.63 $847,990 - $1.12 Million	-6,500 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$146.22 - $169.13 $950,430 - $1.1 Million	6,500 New	6,500 $962,000
Q1 2019 Jun 14, 2019	SELL	$111.31 - $131.02 $968,397 - $1.14 Million	-8,700 Closed	0 $0
Q4 2018 Jun 20, 2019	BUY	$105.9 - $118.64 $921,330 - $1.03 Million	8,700 New	8,700 $1.01 Million
Q3 2018 Jun 20, 2019	SELL	$85.86 - $107.31 $343,440 - $429,240	-4,000 Closed	0 $0
Q2 2018 Jun 20, 2019	BUY	$75.7 - $86.88 $302,800 - $347,520	4,000 New	4,000 $341,000

4,010

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Toews Corp , based on Form 13F filings with the SEC.

Stay updated on Toews Corp with notifications on news.